Quinine - Revision history

Danbot: Fix corrupted content: restore correct Quinine (antimalarial) content, was incorrectly showing Risperidone

2026-03-20T12:10:21Z

Fix corrupted content: restore correct Quinine (antimalarial) content, was incorrectly showing Risperidone

Danbot: Remove disease-specific entries now covered by AntibioticDose (8 sections)

2026-03-20T11:08:44Z

Remove disease-specific entries now covered by AntibioticDose (8 sections)

← Older revision		Revision as of 11:08, 20 March 2026
Line 6:		Line 6:

	==Adult Dosing==		==Adult Dosing==
	~~===[[Schizophrenia]]===~~
	*<65 yo, 1st episode
	**1-3 mg/day PO divided qd/bid
	***Max: 16mg/day
	*<65 yo, maintenance
	**1-4 mg/day PO divided qd/bid
	*65+ yo
	**1-4 mg/day PO divided qd/bid
	***Doses >4 mg/day rarely more effective
	~~===[[Bipolar disorder]], Type 1, Acute manic===~~
	*1-6 mg/day PO divided qd/bid
	**Max: 6 mg/day
	~~===Tourette Syndrome===~~
	*0.25-3 mg/day PO divided qd-bid
	**Max 6 mg/day


Line 36:		Line 21:

	==Pediatric Dosing==		==Pediatric Dosing==
	~~===Pediatric procedural sedation===~~
	*0.01mg/kg/dose IM (typically 0.25-4mg/dose)
	~~===[[Schizophrenia]]===~~
	*1-6 mg/day PO divided qd/bid
	~~===[[Bipolar disorder]], Type 1, Acute mania===~~
	*0.5-6mg/day PO divided qd/bid
	~~===Irritability, Autistic disorder associated===~~
	*0.5-3 mg/day PO divided qd/bid
	~~===Tourrette syndrome===~~
	*0.75-3 mg/day PO divided qd/bid

Danbot: Restore original dosing content alongside dynamic SMW tables

2026-03-20T02:39:18Z

Restore original dosing content alongside dynamic SMW tables

Show changes

Danbot: Replace manual dosing with dynamic SMW tables

2026-03-20T01:54:26Z

Replace manual dosing with dynamic SMW tables

← Older revision		Revision as of 01:54, 20 March 2026
Line 5:		Line 5:

	==Adult Dosing==		==Adult Dosing==
	===[[~~Malaria~~]]~~===~~		===Indications by Disease===
	*648mg PO Q8h x 7 days		{{#ask: [[Has DrugName::Quinine]] [[Has Population::Adult]]
	*See [~~http~~:~~//www.cdc.gov/malaria/resources/pdf/treatmenttable.pdf CDC Recommendations~~] ~~for full treatment recommendations~~		\|?Treats disease=Disease
			\|?Has Dose=Dose
	===~~[[Babesiosis]]~~===		\|?Has Context=Context
	*648mg PO q6-8h x7-10 days		\|format=table
	*Use with [[Clindamycin]]		\|limit=50
			\|mainlabel=-
			\|headers=show
			\|sort=Treats disease
			}}

	==Pediatric Dosing==		==Pediatric Dosing==
	===~~[[Malaria]]~~===		===Indications by Disease===
	*30mg/kg/day PO q8h x 3-7 days		{{#ask: [[Has DrugName::Quinine]] [[Has Population::Pediatric]]
	*Max: ~~648mg/dose~~		\|?Treats disease=Disease
	*See [~~http~~:~~//www.cdc.gov/malaria/resources/pdf/treatmenttable.pdf CDC Recommendations~~] ~~for full treatment recommendations~~		\|?Has Dose=Dose
			\|?Has Context=Context
	~~===~~[[~~Babesiosis~~]]===		\|format=table
	*8mg/kg PO q8h x 7-~~10 days~~		\|limit=50
	*Max: 648mg/dose		\|mainlabel=-
	*Use with [[Clindamycin]]		\|headers=show
			\|sort=Treats disease
			}}

	==Special Populations==		==Special Populations==

ClaireLewis at 22:12, 23 September 2019

2019-09-23T22:12:45Z

← Older revision		Revision as of 22:12, 23 September 2019
Line 1:		Line 1:
	==General==		==General==
	*Type: Antimalarial		*Type: [[Antimalarial]]
	*Dosage Forms: PO 324 (IM and IV formulations available outside US)		*Dosage Forms: PO 324 (IM and IV formulations available outside US)
	*Common Trade Names: Qualaquin		*Common Trade Names: Qualaquin
Line 146:		Line 146:
	<references/>		<references/>
	[[Category:Pharmacology]]		[[Category:Pharmacology]]
			[[Category:ID]]

Bisakson at 17:41, 4 April 2017

2017-04-04T17:41:05Z

@@ Line 118: / Line 118: @@
 ==Administration==
 *Give with food
 ==See Also==

Rossdonaldson1: Text replacement - "Diarrhea" to "Diarrhea"

2016-09-24T16:06:55Z

Text replacement - "*Diarrhea" to "*Diarrhea"

← Older revision		Revision as of 16:06, 24 September 2016
Line 106:		Line 106:
	*Pruritus		*Pruritus
	*Urticaria		*Urticaria
	*Diarrhea		*[[Diarrhea]]
	*Abdominal pain		*Abdominal pain
	*Photosensitivity		*Photosensitivity

Rossdonaldson1: Text replacement - "Hypoglycemia" to "Hypoglycemia"

2016-09-24T15:13:45Z

Text replacement - "*Hypoglycemia" to "*Hypoglycemia"

← Older revision		Revision as of 15:13, 24 September 2016
Line 83:		Line 83:
	*Neutropenia		*Neutropenia
	*[[DIC]]		*[[DIC]]
	*Hypoglycemia		*[[Hypoglycemia]]
	*[[Myasthenia gravis]] exacerbation		*[[Myasthenia gravis]] exacerbation
	*[[Lupus]]		*[[Lupus]]

Neil.m.young: Text replacement - "4 mg" to "4mg"

2016-07-25T20:21:17Z

Text replacement - "4 mg" to "4mg"

← Older revision		Revision as of 20:21, 25 July 2016
Line 29:		Line 29:
	*Renal Dosing		*Renal Dosing
	**Adult		**Adult
	***Severe chronic renal failure: 648mg PO x 1 then ~~324 mg~~ PO q12h		***Severe chronic renal failure: 648mg PO x 1 then 324mg PO q12h
	***If on HD give after dialysis		***If on HD give after dialysis
	**Pediatric		**Pediatric

Neil.m.young: Text replacement - "0 mg" to "0mg"

2016-07-20T18:52:24Z

Text replacement - "0 mg" to "0mg"

← Older revision		Revision as of 18:52, 20 July 2016
Line 15:		Line 15:
	==Pediatric Dosing==		==Pediatric Dosing==
	===[[Malaria]]===		===[[Malaria]]===
	*~~30 mg~~/kg/day PO q8h x 3-7 days		*30mg/kg/day PO q8h x 3-7 days
	*Max: 648mg/dose		*Max: 648mg/dose
	*See [http://www.cdc.gov/malaria/resources/pdf/treatmenttable.pdf CDC Recommendations] for full treatment recommendations		*See [http://www.cdc.gov/malaria/resources/pdf/treatmenttable.pdf CDC Recommendations] for full treatment recommendations